CENBEST CENBEST (also known as Nanjing Xinjiekou Department Store and 南京新街口百货商店股份有限公司) is a company that provides health and elderly care business services. | ![]() Shield Therapeutics Shield Therapeutics is a pharmaceutical company developing and commercializing late-stage, mineral-derived pharmaceuticals. | ![]() CTC Clinical Trial Consultants CTC Clinical Trial Consultants is a company engaging in clinical conduct of hospital-based early phase clinical trials (phase 0/I-IIa) in patients and healthy volunteers. | |||
Founding Date | Founding Date 1972 | Founding Date 1952 | Founding Date 1963 | Founding Date 2008 | Founding Date 2011 |
Type | Type Private | Type Public | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations BR HQ La Tablada, AR Maipú, CL Bogotá, CO Breña, PE | Locations Nanjing, CN HQ Nanjing, CN | Locations Singapore, SG HQ | Locations Gateshead, GB HQ Berlin, DE Wollerau, CH London, GB Wilmington, US | Locations HQ Linköping, SE Lund, SE Uppsala, SE |
Employees | Employees 8,787 | Employees 20,452 | Employees 1,263 | Employees 701% increase | Employees 133 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥6b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) £11.9m (FY, 2018) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods ¥3.8b (FY, 2025) | Cost of goods N/A | Cost of goods £311k (FY, 2018) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit ¥2.5b (FY, 2025) | Gross profit N/A | Gross profit £11.6m (FY, 2018) | Gross profit N/A |
Net income | Net income N/A | Net income (¥731.9m) (FY, 2025) | Net income N/A | Net income (£1.8m) (FY, 2018) | Net income N/A |
CENBEST (also known as Nanjing Xinjiekou Department Store and 南京新街口百货商店股份有限公司) is a company that provides health and elderly care business services.
View company
Shield Therapeutics is a pharmaceutical company developing and commercializing late-stage, mineral-derived pharmaceuticals.
View company
CTC Clinical Trial Consultants is a company engaging in clinical conduct of hospital-based early phase clinical trials (phase 0/I-IIa) in patients and healthy volunteers.
View company